Xiaoxin Ren

587 total citations
17 papers, 402 citations indexed

About

Xiaoxin Ren is a scholar working on Immunology, Oncology and Virology. According to data from OpenAlex, Xiaoxin Ren has authored 17 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Oncology and 4 papers in Virology. Recurrent topics in Xiaoxin Ren's work include Immune Cell Function and Interaction (8 papers), HIV Research and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiaoxin Ren is often cited by papers focused on Immune Cell Function and Interaction (8 papers), HIV Research and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiaoxin Ren collaborates with scholars based in United States, China and Ukraine. Xiaoxin Ren's co-authors include Xingxing Zang, Murali Janakiram, Hao Wang, Deyou Zheng, Phillip M. Galbo, Juan Lin, Amer Assal, Balázs Halmos, Jian‐Hua Wang and Alain Borczuk and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xiaoxin Ren

17 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxin Ren United States 10 239 201 61 47 32 17 402
Carmen Stecher Austria 5 420 1.8× 222 1.1× 75 1.2× 17 0.4× 14 0.4× 11 532
Bettina P. Iliopoulou United States 10 323 1.4× 250 1.2× 101 1.7× 25 0.5× 30 0.9× 15 531
Hyun Tak Jin South Korea 8 446 1.9× 281 1.4× 102 1.7× 13 0.3× 31 1.0× 10 621
Anne‐Laure Puaux France 8 289 1.2× 90 0.4× 108 1.8× 16 0.3× 11 0.3× 12 421
Simone Meuter Switzerland 8 470 2.0× 169 0.8× 73 1.2× 15 0.3× 17 0.5× 9 582
Justin C. Boucher United States 12 254 1.1× 398 2.0× 162 2.7× 12 0.3× 11 0.3× 31 571
Elisa Zaghi Italy 10 274 1.1× 139 0.7× 66 1.1× 7 0.1× 13 0.4× 11 400
Korina G. Veenstra United States 6 317 1.3× 216 1.1× 139 2.3× 26 0.6× 37 1.2× 8 484
Megan S. McAfee United States 7 177 0.7× 200 1.0× 90 1.5× 9 0.2× 66 2.1× 12 315
Pheh-Ping Chang Australia 7 572 2.4× 124 0.6× 138 2.3× 12 0.3× 12 0.4× 8 706

Countries citing papers authored by Xiaoxin Ren

Since Specialization
Citations

This map shows the geographic impact of Xiaoxin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Ren more than expected).

Fields of papers citing papers by Xiaoxin Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Ren. The network helps show where Xiaoxin Ren may publish in the future.

Co-authorship network of co-authors of Xiaoxin Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxin Ren. A scholar is included among the top collaborators of Xiaoxin Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxin Ren. Xiaoxin Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ren, Xiaoxin, et al.. (2025). DDR-YOLO: An Efficient Detection Model Based on YOLO11s for Steel Surface Defect. IEEE Access. 13. 147202–147217. 1 indexed citations
2.
Wang, Hao, R. Alejandro Sica, Gurbakhash Kaur, et al.. (2024). TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature Communications. 15(1). 11–11. 32 indexed citations
3.
Ren, Xiaoxin, et al.. (2022). Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model. STAR Protocols. 3(4). 101818–101818. 1 indexed citations
4.
Ren, Xiaoxin, Mou Peng, Xing Peng, et al.. (2022). Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity. Journal of Clinical Investigation. 132(22). 39 indexed citations
5.
Ren, Xiaoxin, Austin Dulak, Matthew Rausch, et al.. (2022). 489 NPX267, a first-in-class monoclonal antibody targeting KIR3DL3, blocks HHLA2-mediated immunosuppression and potentiates T and NK cell-mediated antitumor immunity. Regular and Young Investigator Award Abstracts. A510–A510. 5 indexed citations
6.
Yao, Wei, Xiaoxin Ren, Phillip M. Galbo, et al.. (2021). KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Science Immunology. 6(61). 65 indexed citations
7.
Ren, Xiaoxin, et al.. (2021). Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities. Genes & Diseases. 9(5). 1181–1193. 14 indexed citations
8.
Chung, Elaine Y., Urvi A. Shah, Yongqiang Wei, et al.. (2019). PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clinical Cancer Research. 25(12). 3589–3601. 17 indexed citations
9.
Chand, Damini, Deepika Dhawan, Alexander Sankin, et al.. (2019). Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model. Bladder Cancer. 5(1). 63–71. 8 indexed citations
10.
Rauch, Daniel A., Kevin C. Conlon, Murali Janakiram, et al.. (2019). Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade. Blood. 134(17). 1406–1414. 78 indexed citations
11.
Cheng, Haiying, Alain Borczuk, Murali Janakiram, et al.. (2018). Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1–Negative Human Lung Cancers. Clinical Cancer Research. 24(8). 1954–1964. 76 indexed citations
13.
Ren, Xiaoxin, Haibo Wang, Chuan Li, et al.. (2016). HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA. Journal of Biological Chemistry. 291(9). 4580–4588. 9 indexed citations
14.
Li, Chuan, Haibo Wang, Xiaoxin Ren, et al.. (2016). Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4 + T Cells. Journal of Virology. 91(1). 16 indexed citations
16.
Ren, Xiaoxin, Li Ma, Chuan Li, et al.. (2014). The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virology Journal. 11(1). 47–47. 19 indexed citations
17.
Jiang, Aiping, Haibo Wang, Li Ma, et al.. (2013). Histamine enhances HIV-1-induced modulation of dendritic cells to skew naïve T cell differentiation toward regulatory T cells. Virology. 442(2). 163–172. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026